Cue Biopharma, Inc. (CUE) Earnings
|
Expand Research on CUE
| Next EPS Date | 8/18/26 | EPS Growth Rate | -3,900.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +14.3% | Revenue Growth Rate | -15.3% |
| Average % Move 1-Wk after EPS | -8.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/26  |
Q226 | N/A | -$3.60 | N/A | N/A | $2.5M | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | N/A | -$3.30 | N/A | N/A | $2.5M | N/A | N/A | N/A | ||
| 3/24/26 |
Q425 | N/A | -$0.09 | N/A | N/A | $2.53M | N/A | N/A | N/A | ||
| 11/13/25 |
Q325 | -$0.07 | -$0.09 | +$0.02 | $2.15M | $2.93M | N/A |  | | Details | |
| 11/10/25 |
Q325 | N/A | -$0.09 | N/A | N/A | $2.93M | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.09 | N/A | N/A | $2.93M | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$0.09 | N/A | N/A | $2.93M | N/A | N/A | N/A | ||
| 8/12/25 |
Q225 | -$0.09 | -$0.14 | +$0.05 | $2.95M | $1.6M | N/A | | | Details |
